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Characterisation
Tool (Native Windows Application), imaging, DICOM.
Upon request the tool may be provided for trial use or
under a license agreement.
Tool description
Dr Eye viewer is an open access, flexible and easy to use
platform for the intuitive annotation and segmentation
of tumor region images (Figure 1). Its clinically driven
development followed an open modular architecture
focusing on plug-in components [1]. Dr Eye’s main
advantage is that the user can quickly and accurately
delineate complex areas in medical images. Additionally,
multiple labels can be set to allow the user to annotate
and manage many different areas of interest in each
selected slide. The close collaboration with clinicians in
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Figure 1 Dr Eye’s user interface. From top left to bottom right: comparison module with statistics among two different annotations in the same
slice; main workspace with one annotation colored in red; 3D visualization of the series; multiple annotations selected with different coloring;
histograms and statistics for each of the annotations.
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designing the platform has ensured that it can be effec-
tively used in the clinical setting.
This tool is suitable for use by various clinicians such
as radiologists or oncologists, and by anyone who needs
to view DICOM images, or perform measurements and
analysis of their imaging data (Figure 1). It can also be
part of the workflow of any clinical environment, from
health centers to hospitals and it supports usage as a
tool in clinical trials or even as training tool in an edu-
cational environment. Dr Eye’s main purpose is to
enable clinicians to efficiently and intuitively annotate
large numbers of 3D tomographic datasets. Both manual
and well-known semi-automatic segmentation techni-
ques are available allowing clinician to annotate multiple
regions of interest during the same session. Additionally,
it includes features like contour drawing, refinement
and labeling that assist in the delineation of tumors.
Segmented tumor regions can be annotated, labeled,
deleted, added and redefined. Interaction with PACS
systems is possible with DICOM Query / Retrieve.
The platform has been tested with hundreds of MRI
datasets to assess and improve usability, extensibility
and robustness. Technically it is based on the .NET fra-
mework architecture and can be used in any Windows
based computer.
Status of development
Version 5.7 released on 1.5.2014, beta version.
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